发明公开
EP2616066A1 ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL]METHANOL FOR TREATING RETINAL DISEASES
有权
[3-（1-（1H-咪唑-4-基）乙基）-2-甲基苯基]甲醇用于治疗视网膜疾病的前药酯
- 专利标题： ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL]METHANOL FOR TREATING RETINAL DISEASES
- 专利标题（中）： [3-（1-（1H-咪唑-4-基）乙基）-2-甲基苯基]甲醇用于治疗视网膜疾病的前药酯
-
申请号： EP11760958.6申请日： 2011-09-16
-
公开(公告)号： EP2616066A1公开(公告)日： 2013-07-24
- 发明人: DIBAS, Mohammed I. , GIL, Daniel W. , CHOW, Ken , WANG, Liming , GARST, Michael E. , DONELLO, John E.
- 申请人： Allergan, Inc.
- 申请人地址： 2525 Dupont Drive Irvine, California 92886 US
- 专利权人： Allergan, Inc.
- 当前专利权人： Allergan, Inc.
- 当前专利权人地址： 2525 Dupont Drive Irvine, California 92886 US
- 代理机构： HOFFMANN EITLE
- 优先权： US383370P 20100916
- 国际公布： WO2012037453 20120322
- 主分类号： A61K31/4174
- IPC分类号： A61K31/4174 ; A61P27/06
摘要：
The present invention relates to method of treating retinal diseases in a subject in need of such treatment, which comprises administering a therapeutically effective amount of a composition comprising a ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
公开/授权文献
信息查询
IPC分类:
